Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Elon Musk's xAI in talks to raise up to $6bn - report

(Sharecast News) - Elon Musk's xAI is reportedly in talks to raise up to $6bn, as the Tesla and X chief looks to global investors, including in Hong Kong, to finance his challenge to Microsoft-backed OpenAI. The Financial Times on Friday cited multiple people familiar with the matter as saying that Musk's artificial intelligence start-up has courted wealthy individuals and investors around the world in recent weeks.

It was understood these talks have included family offices in Hong Kong, the territory that is increasingly controlled by Beijing.

Three people with knowledge of the talks said Musk hoped to raise as much as $6bn in fresh equity capital for xAI at a proposed valuation of $20bn. However, the sources cautioned that negotiations were ongoing and that Musk was still testing investor appetite for such large sums.

One person told the FT he had also targeted sovereign wealth funds in the Middle East, while others said investors in Japan and South Korea had been approached.

Share this article

Related Sharecast Articles

Orosur Mining consultant exercises stock options
(Sharecast News) - Orosur Mining announced the issue of 83,333 new shares on Tuesday, following the exercise of stock options by a company consultant at an exercise price of six Canadian cents per share.
Helium One reports encouraging flow testing at Jackson-29
(Sharecast News) - Helium One Global reported encouraging flow test results from the Jackson-29 well at the Galactica Project in Colorado on Tuesday, where it holds a 50% working interest in a joint venture with Blue Star Helium.
Roche to spend $50bn on US manufacturing, R&D sites
(Sharecast News) - Swiss healthcare giant Roche announced on Tuesday that it is planning to spend $50bn in pharmaceuticals and diagnostics in the US over the next five years.
Ebiquity confident after second-half turnaround
(Sharecast News) - Ebiquity reported a 4.3% decline in revenue to £76.8m for the year ended 31 December on Tuesday, with adjusted operating profit falling 34.3% to £7.9m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.